Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Sell
4,387
-8
-0.2% -$2.74K 0.15% 82
2026
Q1
$1.55M Sell
4,395
-63
-1% -$22.5K 0.18% 69
2025
Q4
$1.46M Buy
4,458
+210
+5% +$66.6K 0.16% 81
2025
Q3
$1.2M Buy
+4,248
New +$1.23M 0.15% 88
2025
Q2
Sell
-8,843
Closed -$2.76M 37
2025
Q1
$2.76M Buy
8,843
+427
+5% +$126K 0.28% 68
2024
Q4
$2.19M Sell
8,416
-1,011
-11% -$300K 0.21% 81
2024
Q3
$3.04M Buy
9,427
+62
+0.7% +$20.3K 0.33% 60
2024
Q2
$2.93M Buy
9,365
+370
+4% +$109K 0.36% 53
2024
Q1
$2.56M Sell
8,995
-2,160
-19% -$632K 0.32% 60
2023
Q4
$3.21M Sell
11,155
-3,021
-21% -$823K 0.41% 43
2023
Q3
$3.81M Sell
14,176
-217
-2% -$54.2K 0.61% 34
2023
Q2
$3.2M Sell
14,393
-295
-2% -$68.5K 0.47% 48
2023
Q1
$3.55M Buy
14,688
+742
+5% +$182K 0.65% 37
2022
Q4
$3.66M Sell
13,946
-138
-1% -$37K 0.67% 30
2022
Q3
$3.17M Buy
14,084
+422
+3% +$102K 0.7% 25
2022
Q2
$3.32M Buy
13,662
+2,136
+19% +$523K 0.7% 20
2022
Q1
$2.79M Buy
11,526
+8,675
+304% +$1.99M 0.54% 29
2021
Q4
$641K Sell
2,851
-130
-4% -$27.4K 0.24% 60
2021
Q3
$634K Buy
2,981
+24
+0.8% +$5.52K 0.25% 58
2021
Q2
$721K Buy
2,957
+18
+0.6% +$4.43K 0.29% 53
2021
Q1
$731K Sell
2,939
-276
-9% -$65.9K 0.32% 49
2020
Q4
$739K Buy
3,215
+17
+0.5% +$3.92K 0.42% 45
2020
Q3
$813K Buy
3,198
+16
+0.5% +$3.96K 0.54% 38
2020
Q2
$750K Buy
3,182
+8
+0.3% +$1.82K 0.6% 36
2020
Q1
$643K Sell
3,174
-251
-7% -$54.8K 0.64% 41
2019
Q4
$826K Buy
3,425
+266
+8% +$58.6K 0.52% 43
2019
Q3
$611K Buy
3,159
+18
+0.6% +$3.46K 0.46% 51
2019
Q2
$579K Sell
3,141
-4,093
-57% -$733K 0.39% 50
2019
Q1
$1.37M Buy
7,234
+3,035
+72% +$580K 0.45% 53
2018
Q4
$817K Sell
4,199
-7,054
-63% -$1.38M 0.62% 39
2018
Q3
$2.33M Buy
11,253
+8,655
+333% +$1.71M 1.15% 16
2018
Q2
$480K Buy
2,598
+198
+8% +$35K 0.36% 53
2018
Q1
$411K Buy
2,400
+2,348
+4,515% +$431K 0.3% 51
2017
Q4
$9K Hold
52
0.01% 263
2017
Q3
$9K Buy
+52
New +$9.21K 0.01% 227
2017
Q1
Sell
-257
Closed -$37K 201
2016
Q4
$37K Buy
+257
New +$38.7K 0.05% 111

Other funds holding AMGN

Legacy Advisors's AMGN Position: Q2 2026 in Review

Legacy Advisors reduced its Amgen (AMGN) stake by 0.18% in Q2 2026, selling an estimated $2.74K and leaving 4,387 shares worth $1.59M. The position accounts for 0.15% of the portfolio, ranked #82.

Legacy Advisors first reported a position in AMGN in Q4 2016 and has held it in 36 quarters since. The position peaked at $3.81M in Q3 2023. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Legacy Advisors held 4,387 shares of Amgen worth $1.59M as of Q2 2026.
  • Legacy Advisors sold 8 Amgen shares in Q2 2026, an estimated $2.74K.
  • Amgen made up 0.15% of Legacy Advisors's portfolio in Q2 2026, its #82 holding.
  • Legacy Advisors first reported a position in Amgen in Q4 2016 and has held it in 36 quarters since.
  • Legacy Advisors's Amgen position peaked at $3.81M in Q3 2023.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Legacy Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.